CPT1A
Basic information
Region (hg38): 11:68754620-68844410
Previous symbols: [ "CPT1" ]
Links
Phenotypes
GenCC
Source:
- carnitine palmitoyl transferase 1A deficiency (Strong), mode of inheritance: AR
- carnitine palmitoyl transferase 1A deficiency (Strong), mode of inheritance: AR
- carnitine palmitoyl transferase 1A deficiency (Supportive), mode of inheritance: AR
- carnitine palmitoyl transferase 1A deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Carnitine palmitoyltransferase deficiency I | AR | Biochemical; Pharmacogenomic | Dietary management, including avoidance of fasting and prompt treatment of hypoglycemia, can prevent and treat metabolic decompensation, and can prevent neurologic damage; Surveillance for hepatic dysfunction may be beneficial, and potentially hepatoxic agents should be avoided | Biochemical; Cardiovascular; Gastrointestinal; Musculoskeletal; Neurologic; Renal | 7014807; 3211616; 1598098; 1403388; 9691089; 10625081; 11286380; 11350182; 12189492; 15110323; 20301700; 20696606; 21962599 |
ClinVar
This is a list of variants' phenotypes submitted to
- Carnitine_palmitoyl_transferase_1A_deficiency (1001 variants)
- not_provided (92 variants)
- Inborn_genetic_diseases (86 variants)
- not_specified (53 variants)
- CPT1A-related_disorder (33 variants)
- CPT1A_POLYMORPHISM (1 variants)
- Metabolic_disease (1 variants)
- CPT1A_ARCTIC_VARIANT (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CPT1A gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001876.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 329 | 345 | |||
missense | 26 | 248 | 26 | 309 | ||
nonsense | 25 | 26 | 56 | |||
start loss | 1 | 1 | ||||
frameshift | 31 | 29 | 63 | |||
splice donor/acceptor (+/-2bp) | 33 | 39 | ||||
Total | 66 | 114 | 270 | 355 | 8 |
Highest pathogenic variant AF is 0.000331712
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CPT1A | protein_coding | protein_coding | ENST00000265641 | 18 | 89791 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.11e-9 | 1.00 | 125703 | 0 | 45 | 125748 | 0.000179 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.64 | 376 | 477 | 0.789 | 0.0000324 | 5079 |
Missense in Polyphen | 78 | 136.08 | 0.57321 | 1424 | ||
Synonymous | 0.284 | 190 | 195 | 0.974 | 0.0000155 | 1486 |
Loss of Function | 3.43 | 22 | 47.5 | 0.463 | 0.00000278 | 486 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000275 | 0.000275 |
Ashkenazi Jewish | 0.000996 | 0.000993 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000159 | 0.000149 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the transfer of the acyl group of long-chain fatty acid-CoA conjugates onto carnitine, an essential step for the mitochondrial uptake of long-chain fatty acids and their subsequent beta-oxidation in the mitochondrion. Plays an important role in triglyceride metabolism.;
- Disease
- DISEASE: Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]: Rare autosomal recessive metabolic disorder of long- chain fatty acid oxidation characterized by severe episodes of hypoketotic hypoglycemia usually occurring after fasting or illness. Onset is in infancy or early childhood. {ECO:0000269|PubMed:11350182, ECO:0000269|PubMed:11441142, ECO:0000269|PubMed:12111367, ECO:0000269|PubMed:12189492, ECO:0000269|PubMed:14517221, ECO:0000269|PubMed:15110323, ECO:0000269|PubMed:15669684, ECO:0000269|PubMed:9691089}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Adipocytokine signaling pathway - Homo sapiens (human);Insulin resistance - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Glucagon signaling pathway - Homo sapiens (human);Fatty acid degradation - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);Long chain acyl-CoA dehydrogenase deficiency (LCAD);Trifunctional protein deficiency;Carnitine palmitoyl transferase deficiency (II);Very-long-chain acyl coa dehydrogenase deficiency (VLCAD);Medium chain acyl-coa dehydrogenase deficiency (MCAD);Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency);Fatty acid Metabolism;Glutaric Aciduria Type I;Ethylmalonic Encephalopathy;Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids;Carnitine palmitoyl transferase deficiency (I);AMP-activated Protein Kinase (AMPK) Signaling;Fatty Acid Beta Oxidation;Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);PPAR Alpha Pathway;Nuclear Receptors Meta-Pathway;RORA activates gene expression;Mitochondrial LC-Fatty Acid Beta-Oxidation;Leptin and adiponectin;PPAR signaling pathway;Liver steatosis AOP;Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways;Signal Transduction;mechanism of gene regulation by peroxisome proliferators via ppara;Circadian Clock;mitochondrial L-carnitine shuttle;Metabolism of lipids;Import of palmitoyl-CoA into the mitochondrial matrix;RORA activates gene expression;Metabolism;Fatty acid metabolism;Signaling by Retinoic Acid;Signaling by Nuclear Receptors;FOXA2 and FOXA3 transcription factor networks
(Consensus)
Recessive Scores
- pRec
- 0.575
Intolerance Scores
- loftool
- 0.0338
- rvis_EVS
- -0.48
- rvis_percentile_EVS
- 22.78
Haploinsufficiency Scores
- pHI
- 0.119
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.494
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.976
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cpt1a
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype;
Gene ontology
- Biological process
- long-chain fatty acid metabolic process;glucose metabolic process;fatty acid beta-oxidation;triglyceride metabolic process;carnitine shuttle;circadian rhythm;carnitine metabolic process;response to organic cyclic compound;regulation of lipid metabolic process;epithelial cell differentiation;positive regulation of fatty acid beta-oxidation;response to drug;eating behavior;regulation of insulin secretion;protein homooligomerization;cellular response to fatty acid
- Cellular component
- mitochondrion;mitochondrial outer membrane;membrane;integral component of mitochondrial outer membrane
- Molecular function
- carnitine O-palmitoyltransferase activity;identical protein binding;palmitoleoyltransferase activity